SARS News and Research

RSS

SARS-CoV-2 Delta binds more strongly to furin protease than other existing variants

Researchers conducted a computational analysis of the furin cleavage domain (FCD) of SARS-CoV-2 and its variants, as well as several other viruses.

10 Jan 2022

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Researchers screened BNT162b2 COVID-19 vaccine recipients and cloned broadly neutralizing antibodies from an elite vaccinee.

10 Jan 2022

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

In a new study, researchers evaluated the neutralizing power of the vaccine against SARS-CoV-2 and vaccine plus infection-induced antibodies against the Omicron variant in a live virus neutralization assay.

10 Jan 2022

Mapping regulatory T-cell populations in COVID-19 patients

In a new study, researchers used mass spectrometry to investigate changes to immune systems, in particular regulatory T-cells (Tregs), in a large cohort of moderate, severe, and critical Japanese coronavirus disease 2019 (COVID-19) patients and healthy controls.

10 Jan 2022

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

New research suggests that viral mutations have a minimal effect on T cell immunity, which could explain the protection provided by vaccination against severe COVID-19, despite the significant loss of neutralizing antibodies.

10 Jan 2022

Effectiveness of prior infection in preventing reinfection with Omicron and other SARS-CoV-2 variants in Qatar

Researchers estimate the effectiveness of prior infection in preventing reinfection (PEs) with Omicron and other SARS-CoV-2 variants for the resident population of Qatar.

10 Jan 2022

Efficacy of surgical masks and N95 respirators in lowering SARS-CoV-2 transmission

In a new study, researchers determined the adherence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant to masks and respirators and the role of buccal protection in controlling SARS-CoV-2 transmission.

10 Jan 2022

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.

10 Jan 2022

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

In a new study, researchers determined three-dose messenger ribonucleic acid (mRNA) vaccinated kidney transplant recipients’ (KTRs) neutralizing responses against SARS-COV-2 variants, breakthrough coronavirus disease 2019 infection rate, and transplant rejection rate.

10 Jan 2022

Social distancing surveillance: how robots will keep you in line

Could a COVID-19 robot help in social distancing surveillance? We spoke to Professor Dinesh Manocha and Adarsh Jagan Sathyamoorthy about how their new robot may be able to do just that.

10 Jan 2022

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

Researchers investigated the incidence of psychiatric diagnoses of Israeli adolescents before and during the COVID-19 pandemic.

10 Jan 2022

Mathematical modeling the vaccination of children against SARS-CoV-2

Researchers evaluated the safety of mRNA vaccination against SARS-CoV-2 in children using mathematical modeling.

10 Jan 2022

Durability of vaccine protection against COVID-19 breakthrough infections and hospitalizations

In a new study, researchers investigated the duration of protection provided by the coronavirus disease 2019 vaccines available in the United States against breakthrough infections, hospitalizations, and intensive care unit admissions.

10 Jan 2022

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

Researchers posted the results of a retrospective observational cohort study in which they determined the humoral and cellular responses in ISP to primary and booster doses of COVID-19 vaccines.

10 Jan 2022

New molecule offers effective protection against coronavirus for at least eight hours

A molecule developed by researchers at the University of Helsinki can inactivate the coronavirus spike protein and offers effective short-term protection against the virus.

10 Jan 2022

Common member of the gut microbiome found to have specific preference for blood group A antigens

Researchers have discovered that a common member of the human gut microbiome has a specific preference for blood group A antigens.

10 Jan 2022

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

A recent study uses an artificial intelligence model to investigate Omicron's mutations and its infectivity, vaccine escape capability, and susceptibility to monoclonal antibodies.

10 Jan 2022

SARS-CoV-2 omicron variant predicted to cause fewer deaths in Florida

Scientists have predicted a lower number of infections and deaths caused by the omicron variant of severe acute respiratory syndrome coronavirus 2 in Florida

10 Jan 2022

SARS-CoV-2 shown to spread through cell-to-cell transmission

A new study investigated SARS-CoV-2 cell-to-cell transmission in the context of cell-free infection and compared it to SARS-CoV.

10 Jan 2022

Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

Researchers have conducted a retrospective matched case-control study to determine the protection period conferred by the BNT162b2 vaccine on adolescents aged 12 to 16.

10 Jan 2022

SARS News and Research

SARS-CoV-2 Delta binds more strongly to furin protease than other existing variants

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

Mapping regulatory T-cell populations in COVID-19 patients

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

Effectiveness of prior infection in preventing reinfection with Omicron and other SARS-CoV-2 variants in Qatar

Efficacy of surgical masks and N95 respirators in lowering SARS-CoV-2 transmission

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

Social distancing surveillance: how robots will keep you in line

Incidence rates of psychiatric diagnoses and drugs in Israeli adolescents before and during the COVID-19 pandemic

Mathematical modeling the vaccination of children against SARS-CoV-2

Durability of vaccine protection against COVID-19 breakthrough infections and hospitalizations

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

New molecule offers effective protection against coronavirus for at least eight hours

Common member of the gut microbiome found to have specific preference for blood group A antigens

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 omicron variant predicted to cause fewer deaths in Florida

SARS-CoV-2 shown to spread through cell-to-cell transmission

Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News